Thomas Englese

Insider Reports History

Location
Silver Spring, MD
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Englese:

Company Role Class Num Shares Value Price $ Report Date Ownership
AZIYO BIOLOGICS, INC. CHIEF COMMERCIAL OFFICER Class A Common Stock 17,917 $43,180 $2.41 09 Mar 2023 Direct
AZIYO BIOLOGICS, INC. CHIEF COMMERCIAL OFFICER Restricted Stock Units 1,875 $4,519 $2.41 08 Mar 2023 Direct
AZIYO BIOLOGICS, INC. CHIEF COMMERCIAL OFFICER Stock Option (Right to Buy) 31,000 08 Mar 2022 Direct

Insider Reports Filed by Thomas Englese

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELUT AZIYO BIOLOGICS, INC. 08 Mar 2023 3 -$1,243 4 CHIEF COMMERCIAL OFFICER 09 Mar 2023, 20:18
ELUT AZIYO BIOLOGICS, INC. 08 Sep 2022 3 -$34,514 4 CHIEF COMMERCIAL OFFICER 12 Sep 2022, 17:05
ELUT AZIYO BIOLOGICS, INC. 08 Mar 2022 6 $0 4 CHIEF COMMERCIAL OFFICER 10 Mar 2022, 19:46
ELUT AZIYO BIOLOGICS, INC. 14 Dec 2021 1 +$27,938 4 CHIEF COMMERCIAL OFFICER 15 Dec 2021, 15:45